Similar articles

• A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia.

  Kjos SL, Schaefer-Graf U, Sardesi S, Peters RK, Buley A, Xiang AH, Bryne JD, Sutherland C, Montoro MN, Buchanan TA. Kjos SL, et al. Diabetes Care. 2001 Nov;24(11):1904-10. doi: 10.2337/diacare.24.11.1904. Diabetes Care. 2001. PMID: 11679455 Clinical Trial.
• Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets.

  Kjos SL, Schaefer-Graf UM. Kjos SL, et al. Diabetes Care. 2007 Jul;30 Suppl 2:S200-5. doi: 10.2337/dc07-s216. Diabetes Care. 2007. PMID: 17596472 Review. No abstract available.
• [Gestational diabetes: insulin therapy in case of normal glycemia?].

  Schäfer-Graf U. Schäfer-Graf U. Dtsch Med Wochenschr. 2008 Feb;133(6):264. doi: 10.1055/s-2008-1046706. Dtsch Med Wochenschr. 2008. PMID: 18236359 German. No abstract available.
• Management of gestational diabetes: pharmacologic treatment options and glycemic control.

  Langer O. Langer O. Endocrinol Metab Clin North Am. 2006 Mar;35(1):53-78, vi. doi: 10.1016/j.ecl.2005.09.007. Endocrinol Metab Clin North Am. 2006. PMID: 16310642 Review. No abstract available.
• The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial.

  Ibrahim MI, Hamdy A, Shafik A, Taha S, Anwar M, Faris M. Ibrahim MI, et al. Arch Gynecol Obstet. 2014 May;289(5):959-65. doi: 10.1007/s00404-013-3090-7. Epub 2013 Nov 12. Arch Gynecol Obstet. 2014. PMID: 24217938 Clinical Trial.